XML 42 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Investments (Tables)
12 Months Ended
Dec. 31, 2018
Investments [Abstract]  
Schedule of Investments
Total investments at December 31, 2018 were as follows:
In millions
Current
 
Long-term
 
Total
Debt securities available for sale
$
2,359

 
$
12,896

 
$
15,255

Mortgage loans
145

 
1,216

 
1,361

Other investments
18

 
1,620

 
1,638

Total investments
$
2,522

 
$
15,732

 
$
18,254

 
 
 
 
 
 

Schedule of Debt Securities AFS
Debt securities available for sale at December 31, 2018 were as follows:
In millions
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
December 31, 2018
 
 
 
 
 
 
 
Debt securities:
 
 
 
 
 
 
 
U.S. government securities
$
1,662

 
$
26

 
$

 
$
1,688

States, municipalities and political subdivisions
2,370

 
30

 
(1
)
 
2,399

U.S. corporate securities
6,444

 
61

 
(16
)
 
6,489

Foreign securities
2,355

 
31

 
(3
)
 
2,383

Residential mortgage-backed securities
567

 
10

 

 
577

Commercial mortgage-backed securities
594

 
11

 

 
605

Other asset-backed securities
1,097

 
3

 
(15
)
 
1,085

Redeemable preferred securities
30

 

 
(1
)
 
29

Total debt securities (1)
$
15,119

 
$
172

 
$
(36
)
 
$
15,255

 
 
 
 
 
 
 
 
_____________________________________________ 
(1)
Investment risks associated with the Company’s experience-rated products generally do not impact the Company’s consolidated results of operations. At December 31, 2018, debt securities with a fair value of $916 million, gross unrealized capital gains of $12 million and gross unrealized capital losses of $2 million were included in total debt securities, but support experience-rated products.
Investments Classified by Contractual Maturity Date
The fair value of debt securities at December 31, 2018 is shown below by contractual maturity.  Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.
In millions
Amortized Cost
 
Fair Value
Due to mature:
 
 
 
Less than one year
$
901

 
$
902

One year through five years
5,489

 
5,521

After five years through ten years
2,973

 
2,999

Greater than ten years
3,498

 
3,566

Residential mortgage-backed securities
567

 
577

Commercial mortgage-backed securities
594

 
605

Other asset-backed securities
1,097

 
1,085

Total
$
15,119

 
$
15,255

 
 
 
 

Schedule of AFS In Unrealized Capital Loss Position
The maturity dates for debt securities in an unrealized capital loss position at December 31, 2018 were as follows:
 
Supporting experience-rated products
 
Supporting remaining
products
 
Total
In millions
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
 
Fair
Value
 
Unrealized
Losses
Due to mature:
 
 
 
 
 
 
 
 
 
 
 
Less than one year
$
21

 
$

 
$
308

 
$

 
$
329

 
$

One year through five years
36

 
2

 
557

 
5

 
593

 
7

After five years through ten years
47

 

 
492

 
9

 
539

 
9

Greater than ten years
49

 

 
370

 
5

 
419

 
5

Residential mortgage-backed securities

 

 
1

 

 
1

 

Other asset-backed securities
4

 

 
524

 
15

 
528

 
15

Total
$
157

 
$
2

 
$
2,252

 
$
34

 
$
2,409

 
$
36

 
 
 
 
 
 
 
 
 
 
 
 

Summarized below are the debt securities the Company held at December 31, 2018 that were in an unrealized capital loss position:
In millions, except number of securities
Number of Securities
 
Fair
Value
 
Unrealized
Losses
Debt securities:
 
 
 
 
 
U.S. government securities
8

 
$
26

 
$

States, municipalities and political subdivisions
54

 
86

 
1

U.S. corporate securities
1,399

 
1,431

 
16

Foreign securities
243

 
314

 
3

Residential mortgage-backed securities
45

 
1

 

Other asset-backed securities
516

 
528

 
15

Redeemable preferred securities
14

 
23

 
1

Total debt securities
2,279

 
$
2,409

 
$
36

 
 
 
 
 
 

Activity in Mortgage Loan Portfolio

The Company’s mortgage loans are collateralized by commercial real estate. From the Aetna Acquisition Date through December 31, 2018, the Company had the following activity in its mortgage loan portfolio:
In millions
 
New mortgage loans
$
4

Mortgage loans fully-repaid
27

Mortgage loans foreclosed



Based upon the most recent assessments at December 31, 2018, the Company’s mortgage loans were given the following credit quality indicators:
In millions, except credit ratings indicator
 
1
$
42

2 to 4
1,301

5 and 6
18

7

Total
$
1,361

 
 

At December 31, 2018 scheduled mortgage loan principal repayments were as follows:
In millions
 
2019
$
145

2020
109

2021
269

2022
228

2023
83

Thereafter
527

Total
$
1,361

 
 

Investment Income

Sources of net investment income for the year ended December 31, 2018 were as follows:
In millions
 
Debt securities
$
61

Mortgage loans
6

Other investments
593

Gross investment income
660

Investment expenses
(3
)
Net investment income (excluding net realized capital gains or losses)
657

Net realized capital gains
3

Net investment income (1)
$
660

 
 
_____________________________________________ 
(1)
Net investment income in 2018 includes $4 million related to investments supporting experience-rated products.
Realized Gain (Loss) on Investments

Excluding amounts related to experience-rated products, proceeds from the sale of available for sale debt securities and the related gross realized capital gains and losses from the Aetna Acquisition Date through December 31, 2018 were as follows:(1) 
In millions
 
Proceeds from sales
$
389

Gross realized capital gains
2

Gross realized capital losses
(2
)
 
 
_____________________________________________ 
(1)
The proceeds from sales and gross realized capital gains and losses exclude the impact of the sales of short-term debt securities which primarily relate to the Company’s investments in mutual funds. These investments were excluded from the disclosed amounts because they represent an immaterial amount of aggregate gross realized capital gains or losses and have a high volume of sales activity.